A newly launched fund signals confidence in Chicago's potential to become a leading life sciences hub. Learn more here.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...

Trump attacks Illinois’ "No Cash Bail" initiative and weighs sending the National Guard to Chicago; Gov. JB Pritzker and Chicago Mayor Johnson push back.

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

AbbVie (NYSE: ABBV) has unveiled a $195 million investment to expand its North Chicago manufacturing plant to include domestic active pharmaceutical ingredient (API) production. The expansion is part ...

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

The Chicago Sky soon may be one of only four WNBA teams with fully independent ownership. Could that change? And would Bulls ...

AbbVie is investing $195 million in its North Chicago manufacturing plant to expand domestic drug production. It's part of the company's previously announced $10 billion U.S. capital plan, which the ...

Following a comprehensive entertainment market study on the River Center expansion and hotel project, Chicago company Hunden ...

The executive leading a massive battery factory expansion went from Army sniper to the corporate ranks. Get his story, and ...

Mayor Brandon Johnson said city and state finances are at a " point of no return " and imposed hiring limits as his finance ...